Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose albendazole for Ascaris lumbricoides infection in Ethiopian schoolchildren
PACTR202407793260730Phase 1Completed
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of albendazole in ascariasis. Primary endpoint: Cure rate. Started Jun 2023; status: completed.
02
Drugs
albendazole
03
Conditions
ascariasis
Beyond the preview
Go deeper on PACTR202407793260730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407793260730.